CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close

Science and Research

Derby: Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

This is a 24-month study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy secondary to age-related macular degeneration.

Overview

This is a Phase III, multicentre, randomised, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in patients with geographic atrophy secondary to age-related macular degeneration.

  • Principal Investigator
Associate Professor Sanj Wickremasinghe

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.

Read More

Related Pages

Clinical trials

Refer a patient

We welcome referrals from healthcare practitioners of patients who may be suitable for a clinical trial at CERA.

Clinical trials

Register your interest in clinical trials

To express interest in taking part in current or future clinical trials at CERA, please join our online database below. First, here are some important things you need to know.